1
Clinical Trials associated with LY-4060874A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4060874 in Healthy Participants
The purpose of this study is to evaluate safety and tolerability of LY4060874 in healthy participants.
Study participation may last up to 22 weeks and up to approximately 16 study visits.
100 Clinical Results associated with LY-4060874
100 Translational Medicine associated with LY-4060874
100 Patents (Medical) associated with LY-4060874
100 Deals associated with LY-4060874